| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/22/2011 | WO2011092720A3 Pharmaceutical composition of prasugrel and its pharmaceutically acceptable salts and process for their preparation |
| 09/22/2011 | WO2011056477A3 Methods for treating inflammation and oxidative stress related diseases |
| 09/22/2011 | WO2011053792A3 Methods and compositions for sustained delivery of drugs |
| 09/22/2011 | US20110230816 Gels for Transdermal Delivery |
| 09/22/2011 | US20110230568 Heating of polymers and other materials using radiation for drug delivery and other applications |
| 09/22/2011 | US20110230555 Enzyme Inhibitors and the Use Thereof |
| 09/22/2011 | US20110230553 Crystallized form of dronedarone base |
| 09/22/2011 | US20110230550 Compounds, compositions and methods |
| 09/22/2011 | US20110230544 Modulation of c-reactive protein expression |
| 09/22/2011 | US20110230540 Manassatin compounds and methods of making and using the same |
| 09/22/2011 | US20110230532 Nitrooxy cycloalkane derivatives |
| 09/22/2011 | US20110230520 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
| 09/22/2011 | US20110230517 Calcium receptor modulating agents |
| 09/22/2011 | US20110230516 CCR1 Antagonists and Methods of Use Therefor |
| 09/22/2011 | US20110230508 Novel Forms of a Fused Pyrrolocarbazole Compound |
| 09/22/2011 | US20110230507 Piperidine GPCR Agonists |
| 09/22/2011 | US20110230501 Pharmaceutical compositions for the treatment of diabetes mellitus |
| 09/22/2011 | US20110230498 Biaryl carboxamides |
| 09/22/2011 | US20110230494 Heteroaryl compounds and uses thereof |
| 09/22/2011 | US20110230493 1-OXA-8-Azaspiro [4,5] Decabe-8-Carboxamide Compounds as FAAH Inhibitors |
| 09/22/2011 | US20110230490 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 09/22/2011 | US20110230487 Arylsulfonamide ccr3 antagonists |
| 09/22/2011 | US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/22/2011 | US20110230484 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators |
| 09/22/2011 | US20110230477 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
| 09/22/2011 | US20110230470 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors |
| 09/22/2011 | US20110230468 Fused heterocyclic compounds and uses thereof |
| 09/22/2011 | US20110230466 Association of a sinus node if current inhibitor and calcium inhibitor and pharmaceutical compositions containing it |
| 09/22/2011 | US20110230464 Purine derivatives useful as p13 kinase inhibitors |
| 09/22/2011 | US20110230462 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230461 2,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives |
| 09/22/2011 | US20110230460 Thienotriazolodiazepine derivatives active on apo a |
| 09/22/2011 | US20110230459 Lactam acetamides as calcium channel blockers |
| 09/22/2011 | US20110230458 Phenyl-heteroaryl derivatives and methods of use thereof |
| 09/22/2011 | US20110230452 Compounds and methods for the treatment of pain and other diseases |
| 09/22/2011 | US20110230440 Inhibitors of fatty acid amide hydrolase |
| 09/22/2011 | US20110230435 Methods and Compositions for Treating Obesity and Related Disorders |
| 09/22/2011 | US20110230426 Template-fixed peptidomimetics |
| 09/22/2011 | US20110230414 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230412 Neuregulin Peptides And Their Use |
| 09/22/2011 | US20110230410 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY |
| 09/22/2011 | US20110230409 GLP-I Agonist And Cardiovascular Complications |
| 09/22/2011 | US20110230405 Peptides and Supported Peptides for Treating Skin Diseases |
| 09/22/2011 | US20110229944 FAD4, FAD5, FAD5-2, AND FAD6, Novel Fatty Acid Desaturase Family Members and Uses Thereof |
| 09/22/2011 | US20110229577 Biologically active silicic acid |
| 09/22/2011 | US20110229571 Pharmaceutical Compositions Comprising a Selective I1 Imidazoline Receptor Agonist and an Angiotensin II Receptor Blocker |
| 09/22/2011 | US20110229570 Orally rapidly disintegrating tablet and process for producing same |
| 09/22/2011 | US20110229567 Solid pharmaceutical composition |
| 09/22/2011 | US20110229564 Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof |
| 09/22/2011 | US20110229549 Methods and Compositions for Enhancing Vascular Access |
| 09/22/2011 | US20110229546 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors |
| 09/22/2011 | US20110229525 Modulation of cytokine signaling |
| 09/22/2011 | US20110229499 Method for treatment of vascular hyperpermeability |
| 09/22/2011 | US20110229475 Novel compounds |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229460 anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 09/22/2011 | US20110229455 Stabilized liquid and lyophilized adamts13 formulations |
| 09/22/2011 | US20110229444 Neuregulin And Cardiac Stem Cells |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | US20110226650 Antibody formulation |
| 09/22/2011 | CA2793523A1 Cyclopropanecarboxylic acid derivative |
| 09/22/2011 | CA2793413A1 Crystal form of edoxaban tosylate monohydrate and method of producing same |
| 09/22/2011 | CA2793125A1 New enzyme inhibitor compounds |
| 09/22/2011 | CA2791505A1 Cycloalkyl-substituted imidazole derivative |
| 09/22/2011 | CA2791081A1 Treatment for pulmonary hypertension |
| 09/22/2011 | CA2697564A1 Use of the clopidogrel with asa for the preparation of a medicament for use in the prevention of major vascular events |
| 09/21/2011 | EP2366774A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366773A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366772A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366771A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366706A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 09/21/2011 | EP2366699A1 8-substituted isoquinoline derivative and use thereof |
| 09/21/2011 | EP2366431A1 Myeloperoxidase as a target in atrial fibrillation |
| 09/21/2011 | EP2366393A2 Roflumilast for the treatment of pulmonary hypertension |
| 09/21/2011 | EP2366389A1 Severe sepsis preventive therapeutic agent |
| 09/21/2011 | EP2365955A1 Aryl di-substituted propenone compounds |
| 09/21/2011 | EP2365813A2 Methods of reducing the risk of cardiovascular disease in postmenopausal women |
| 09/21/2011 | EP2365808A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury |
| 09/21/2011 | EP2103610B1 Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof |
| 09/21/2011 | EP1843771B1 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity |
| 09/21/2011 | EP1519956B1 Epha2 monoclonal antibodies and methods of use thereof |
| 09/21/2011 | EP1487428B1 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/21/2011 | EP1436298B1 Himbacine analogues as thrombin receptor antagonists |
| 09/21/2011 | CN201978335U 一种脑循环保健治疗袋 Kind of brain circulation health treatment bag |
| 09/21/2011 | CN201977364U 一种中草药枕芯 One kind of herbal pillow |
| 09/21/2011 | CN1981822B Tree-peony root bark effective component, its preparation, making method and use |
| 09/21/2011 | CN1919252B Medicine for treating cardiovascular and cerebrovascular disease |
| 09/21/2011 | CN102197031A Substituted 5-aminopyrazoles and use thereof |
| 09/21/2011 | CN102197028A Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders |
| 09/21/2011 | CN102197017A Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders |
| 09/21/2011 | CN102196810A Pharmaceutical composition improved in absorption through intestinal tract |
| 09/21/2011 | CN102196809A Agent for treatment of diabetic nephropathy |
| 09/21/2011 | CN102196733A Method for concentrating lipid |
| 09/21/2011 | CN102191221A Neural stem cell capable of self-renewing, preparation method and application thereof |
| 09/21/2011 | CN102191209A VEGF165 and Ang-1 double-gene co-expression vector and application thereof |
| 09/21/2011 | CN102191158A Medicinal liquor having adjuvant treatment efficacy |
| 09/21/2011 | CN102191131A Systemic preparation method of chrysanthemum rice essential oil, chrysanthemum rice polysaccharide, chrysanthemum total flavone extract and chrysanthemum rice powder |
| 09/21/2011 | CN102190706A Novel loach protein antihypertensive peptide and preparation method thereof |
| 09/21/2011 | CN102190661A Tricyclic benzopyran compound as anti-arrhythmic agents |
| 09/21/2011 | CN102190659A Phenylpyrazine compounds, and preparation method and medicinal application thereof |